Arkray
For more than 60 years, ARKRAY has developed innovative diagnostic and monitoring products including automated systems for urinalysis, A1C, clinical chemistry instruments, reagents and consumables. In addition, ARKRAY is a leader in the blood glucose monitoring market with a dominant market share in long term care. ARKRAY continues to evolve and innovate its product lines and programs to meet the changing needs of the industry.
Headquarters
Kyoto, Japan
Company Size
2,501(Data 2021/11/1)
-
OCT 24, 2024 | 5:00 AMC.E. CREDITS
Urinalysis is a major diagnostic screening test in the clinical laboratory, with an important role in diagnosing and monitoring nephrological and urological conditions. Until recently, micro... -
MAR 15, 2023 | 3:00 PM
Date: March 15, 2023 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CET) Presentation - Prof. Andrea Mosca: “Monitoring glycemic control in diabetic pat...
-
SEP 13, 2016 | 12:30 PM
Urinalysis is one the oldest, most established, and most frequently ordered laboratory tests. However, there is wide variation in the methods, processes, quality checks, specifications,...
